Desenfriol-D is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Salimex, S.a.. The primary component is Chlorpheniramine Maleate; Phenylephrine Hydrochloride; Acetaminophen.
Product ID | 53666-617_5bee1a0b-7c7a-cdca-e053-2991aa0a95ed |
NDC | 53666-617 |
Product Type | Human Otc Drug |
Proprietary Name | Desenfriol-D |
Generic Name | Chlorpheniramine Maleate, Phenylephrine Hydrochloride, Acetaminophen |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-10-18 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Salimex, S.A. |
Substance Name | CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN |
Active Ingredient Strength | 0 g/g; g/g; g/g |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2017-10-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2017-10-18 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-03-02 |
Ingredient | Strength |
---|---|
CHLORPHENIRAMINE MALEATE | .002 g/g |
SPL SET ID: | 5bee1a0b-7c79-cdca-e053-2991aa0a95ed |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
53666-417 | Desenfriol-D | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN |
53666-517 | Desenfriol-D | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN |
53666-617 | Desenfriol-D | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DESENFRIOL-D 78929863 not registered Dead/Abandoned |
Schering Corporation 2006-07-14 |
DESENFRIOL-D 73158265 1101928 Dead/Cancelled |
SCHERING CORPORATION 1978-02-10 |